Metoclopramide Syrup

Quick links

Choose a section

Quick links to important sections

Advertisements

Metoclopramide Syrup

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Metoclopramide Syrup

Property Description
Active ingredient Metoclopramide (as hydrochloride)
Form Oral solution / Syrup
Pharmacological class Prokinetic agent, Antiemetic
General purpose Relieves nausea, promotes gastric motility
Origin Synthetic compound

What Type of Medicine is Metoclopramide Syrup?

Metoclopramide Syrup is a prescription-only medication that is both a prokinetic agent and an antiemetic. The active compound is Metoclopramide, a synthetic compound that belongs to the benzamide derivative chemical class. This unique classification determines its capability to influence both the digestive system and the central nervous system signals related to sickness. Its designation as a prokinetic agent signifies its fundamental role in enhancing upper gastrointestinal motility. Metoclopramide is a recognized medication for motility disorders. This means the medication is used for helping the digestive system push contents through efficiently.


Composition and Form: Why is Metoclopramide Syrup a Liquid?

This medication is an oral solution or liquid formulation, designed for efficient consumption via the enteral route. The syrup base consists of the active substance, typically Metoclopramide hydrochloride, dissolved in an aqueous vehicle. The formulation as a liquid, rather than a solid tablet, provides critical differentiation, particularly for pediatric patients or adults experiencing conditions such as dysphagia (difficulty swallowing). This specific liquid form is designed to facilitate quick and easy ingestion, which is often crucial when the individual is acutely experiencing vomiting.


What is the General Purpose of a Prokinetic Antiemetic?

The general therapeutic purpose of this drug is to address two core issues simultaneously: promoting proper gastric emptying and suppressing the central signals for sickness. This dual action provides the benefit of both physically accelerating food transit and centrally relieving the uncomfortable symptoms of nausea and vomiting. Metoclopramide has an established utility for managing acute symptoms of sickness across different patient groups.

Regulatory References

  1. NIH DailyMed Monograph
  2. WHO Essential Medicines List
Advertisements

What side effects are possible with Metoclopramide Syrup?

Possible Side Effects and Safety Information

The safety profile of metoclopramide is defined by regulatory documents based on frequency and affected physiological systems. The most frequently occurring adverse reaction is drowsiness, which is classified as very common in official regulatory summaries.


Neurological Safety and Extrapyramidal Risk

The medicine is associated with effects on the Nervous System and Psychiatric health, some of which are classified as common. These include depression, general feelings of asthenia, and extrapyramidal disorders such as parkinsonism and akathisia. Extrapyramidal reactions are noted to be more frequently observed at the start of treatment and are related to the administered dose. Children and young adults have an increased susceptibility to these reactions.

Risk of tardive dyskinesia, a serious and potentially irreversible movement disorder, is explicitly linked to longer duration of treatment and cumulative dose, and requires special consideration, particularly in older adults. Serious, rare reactions include Neuroleptic Malignant Syndrome (NMS) and seizures.


Other Adverse Reactions and Restrictions

Effects on the Gastrointestinal System commonly involve diarrhoea. In the Cardiac Disorders category, bradycardia is classified as uncommon, while severe events such as cardiac arrest have been documented, especially with non-oral administration. Hypersensitivity reactions, including anaphylaxis, are also noted in the safety profile.

Use is officially contraindicated in individuals with conditions such as gastrointestinal haemorrhage, mechanical obstruction, or perforation. Dose adjustments are required for patients with confirmed severe renal impairment or severe hepatic impairment.

Advertisements

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

The regulatory profile for metoclopramide overdose describes manifestations primarily affecting the central nervous system. Documented presentations include somnolence, disorientation, lethargy, and seizures. The most common clinical signs of overdose are extrapyramidal reactions, such as dystonia, dyskinesia, and akathisia. While many symptoms are reported as self-limiting and resolve within 24 hours, severe overdoses are associated with life-threatening manifestations. These serious outcomes, which require urgent response, include cardio-vascular collapse, severe bradycardia, cardiac arrest, and respiratory arrest. Infants and children are noted as being susceptible to severe extrapyramidal reactions and methemoglobinemia following overdose exposure.

When to Seek Urgent Medical Help and Management

Official guidance mandates that immediate medical attention must be sought for the appearance of any serious or life-threatening symptoms, such as circulatory collapse or seizures. Continuous monitoring of vital functions is required until clinical symptoms fully resolve. The management of overdose is defined as primarily symptomatic and supportive. Regulatory documents state that no specific antidote is known for metoclopramide. However, specific treatments like anticholinergic medicinal products or benzodiazepines may be administered to control extrapyramidal reactions.

Advertisements

Therapeutic Uses of Metoclopramide Syrup

What Metoclopramide Syrup Treats: Main Uses and Benefits

Metoclopramide syrup is a medication used to manage various symptoms related to physical discomfort and is indicated for situations involving certain distressing symptoms.


Relief from Intense Nausea and Vomiting

This medication is applied in areas where short-term symptom management is appropriate, helping to address symptom clusters that may become intense or disruptive. It is relevant in contexts marked by increased discomfort or tension, such as severe or persistent nausea and vomiting that creates noticeable physiological strain, commonly used during phases when symptoms become more noticeable.


Managing Symptoms Linked to Functional Stress

Metoclopramide syrup is applied across domains where additional symptomatic support is needed, especially in conditions marked by increased physiological stress. It is relevant for easing symptoms that interfere with daily functioning, such as symptoms related to systemic imbalance or heightened physiological activity. This use provides support that helps ease the overall symptom burden.


Quick Facts: Therapeutic Focus

The syrup is generally used in settings marked by temporary physiological imbalance and may assist with maintaining functional stability during symptomatic phases.

Advertisements

Eligibility and Restrictions for Use

Official Eligibility Profile

The eligibility for Metoclopramide Syrup is strictly governed by regulatory documentation, which outlines populations that are ineligible, restricted, or require special consideration.

Eligibility Domain Regulatory Status
Infants (Under 1 Year) Contraindicated (Explicitly prohibited due to neurological risks).
Children (1–18 Years) Restricted Use (Limited to specific second-line indications with a maximum duration of 5 days in the EU/UK).
Pre-existing Conditions Contraindicated (Includes patients with epilepsy, Parkinson’s disease, pheochromocytoma, history of tardive dyskinesia, or gastrointestinal hemorrhage/perforation).
Severe Organ Impairment Conditional Use (Mandatory dose reduction is required for patients with severe renal or hepatic impairment).
Pregnancy/Lactation Restricted/Not Recommended (Avoided in late pregnancy; not recommended during breastfeeding).

Use for all eligible adults is subject to strict duration limits, typically not exceeding twelve weeks, to mitigate the risk of developing neurological disorders, as specified in regulatory labeling.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information documents three primary categories of interactions for metoclopramide syrup: pharmacodynamic, pharmacokinetic, and formal restrictions.

Documented Pharmacological Restrictions

Co-administration with Levodopa or other dopaminergic agonists is contraindicated due to mutual pharmacological antagonism that counteracts the effectiveness of the dopaminergic agent. A similar restriction applies to Monoamine Oxidase Inhibitors (MAOIs) due to the risk of hypertensive crisis.

Pharmacodynamic and Additive Effects

Metoclopramide has additive effects with substances that cause Central Nervous System (CNS) depression, including alcohol, opiates, sedatives, and anxiolytics, which increases the overall risk of sedation. Concomitant use with other neuroleptics (antipsychotics) or serotonergic drugs (e.g., SSRIs) may increase the risk of extrapyramidal disorders or serotonin syndrome, respectively. Anticholinergic drugs and morphine derivatives may exhibit a mutual antagonism, reducing the prokinetic action.

Pharmacokinetic Interactions

Metoclopramide's prokinetic action can modify the absorption rate of co-administered oral medications; this is specifically noted to decrease the bioavailability of Digoxin and increase the exposure of Cyclosporine. Co-administration with strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) results in increased systemic exposure and plasma concentrations of metoclopramide. Furthermore, the risk of metoclopramide drug accumulation is officially noted for patients with renal impairment or who are CYP2D6 poor metabolizers due to slower elimination.

Advertisements

Mechanism of Action

The final output must be 100-200 words

How Metoclopramide Syrup Works

Metoclopramide exhibits a dual mechanism of action, influencing both central and peripheral nervous systems by modulating key neurotransmitter pathways. This multi-modal approach engages two separate pathways that contribute to the compound's overall pharmacological action on the digestive system.

Central Signal Blockade via D2 and 5 HT3 Antagonism

This mechanism involves the drug acting as an antagonist (blocker) at dopamine D2 receptors and serotonin 5 HT3 receptors within the Chemoreceptor Trigger Zone (CTZ). The CTZ monitors the bloodstream for chemical irritants; by blocking the receptors in this area, metoclopramide prevents the propagation of activating signals from the CTZ to the central vomiting center, altering the signal sequence that precedes the emetic reflex.

Peripheral Pathway Activation and Motility Modulation

In the upper gastrointestinal tract, the drug acts by blocking peripheral D2 receptors, which normally inhibit muscle movement, and simultaneously acts as an agonist (stimulator) at serotonin 5 HT4 receptors on enteric nerves. This dual modulation enhances the local release of Acetylcholine (ACh). The resulting increase in ACh modulates the smooth muscle, increasing the amplitude and rhythmicity of contractions in the stomach and small intestine, which increases the rate of gastric emptying.

Metoclopramide's prokinetic mechanism is primarily active in the upper digestive tract (esophagus and stomach). The central antiemetic mechanism targets pathways activated by circulating chemical triggers, but its activity is minimal in pathways mediated by the vestibular system, which involves different histaminergic receptors.

Advertisements

Dosage and Administration Information

Administration Overview

Metoclopramide syrup is an oral solution typically administered using a specific measuring device to ensure the correct volume is consumed. It is generally taken on an empty stomach, often 30 minutes before meals and at bedtime, depending on the frequency recommended by a healthcare provider.

Measuring the Dose

To ensure accuracy, it is important to use a medicinal measuring spoon, oral syringe, or graduated cup. Household spoons are not recommended as they vary in size and may lead to an incorrect amount of medication being taken. If an oral syringe is used, the measurement should be read at the level of the plunger as indicated by the markings on the barrel.

Usage Duration

This medication is intended for short-term use. Treatment duration is typically limited to a specific window of time to minimize the risk of cumulative effects. If a dose is missed, it is usually advised to skip the missed dose and resume the regular schedule rather than taking a double dose.

Storage and Handling

The syrup should be stored at room temperature, away from direct light and moisture. The bottle should be kept tightly closed when not in use. It is important to keep the medication out of the reach of children and pets.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Metoclopramide Syrup

Evidence for Use in Digestive Motility Disorders

Research has explored this medication’s role in Diabetic Gastroparesis using short-term clinical trials and Systematic Reviews. Studies monitored objective outcomes like gastric emptying rate alongside patient-reported common symptoms (vomiting, fullness). The findings describe patterns related to changes in measured gastric emptying. However, long-term effects are not fully established, and in some studies, changes in emptying did not consistently align with reported symptom changes.


Evidence for Use in Managing Acute Nausea and Vomiting

The evidence base includes Meta-analyses of Randomized Controlled Trials evaluating its evaluation in Postoperative Nausea and Vomiting (PONV) and Chemotherapy-Induced Nausea and Vomiting (CINV). Researchers monitored outcomes related to the frequency of vomiting episodes and severity of nausea. Findings describe patterns related to changes in the incidence of vomiting, but the observed change in measured nausea severity was often less pronounced. The evidence base for acute CINV is limited in some settings.


Research on Its Role in Symptomatic Reflux and Procedural Support

The medication was observed in studies for Symptomatic Gastroesophageal Reflux Disease (GERD), primarily in populations studied after failure of initial therapies. Findings regarding sustained symptom changes were mixed, and evidence is limited. In procedural settings, acute studies monitored physiological outcomes like gastric emptying time, showing patterns related to changes in the measured speed of passage of stomach contents for procedures like tube placement.


Understanding Evidence Gaps and Uncertainties

The research highlights several key limitations. The majority of trials had limited follow-up durations, meaning long-term effects are not fully established. Comparative evidence is lacking in many settings, particularly when evaluating this medication against newer drug options for CINV and GERD. Furthermore, inconsistent findings have been noted, such as the variability between objective measures and patient-reported discomfort. The results apply only to the specific populations studied under trial conditions.

Key Studies & References

  1. Metoclopramide - StatPearls (Source covering indications, dosing duration, and regulatory context)
  2. Efficacy of current antiemetic treatments for preventing delayed chemotherapy-induced nausea and vomiting: a meta-analysis of randomized controlled trials
  3. Management of Refractory Gastroesophageal Reflux Disease (Palliative Care Network of Wisconsin, discussing metoclopramide use in specific refractory populations)
  4. Metoclopramide Injection, USP (Pfizer Labeling covering small bowel intubation and radiological examination use)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Metoclopramide Syrup (FAQ)


Q: How quickly does Metoclopramide Syrup start working after taking it?

According to the official prescribing information, the onset of action for metoclopramide after taking an oral dose is generally noted to be between 30 and 60 minutes. This time frame describes the period where the medication's effects are typically first observed.


Q: How long do the effects of Metoclopramide Syrup typically last?

Official pharmacological information indicates that the effects of a single oral dose of metoclopramide are typically described as lasting for approximately 1 to 2 hours. This duration guides how frequently the medication is scheduled for use.


Q: Is it necessary to take Metoclopramide Syrup with food?

Official directions are to administer the medication on an empty stomach (30 minutes before each meal and at bedtime). This timing is intended to help maximize the medication’s absorption.


Q: Is Metoclopramide Syrup safe for people with kidney issues?

For patients who have moderate to severe renal dysfunction (issues with kidney function), regulatory documents indicate that a dose reduction is required. Official labeling does not typically recommend a dose adjustment for mild kidney dysfunction.


Q: What happens if I miss a scheduled amount of the syrup?

The manufacturer's directions regarding a missed dose indicate that it should be skipped. The next dose should then be taken at the regularly scheduled time. It is specifically noted not to take a double dose to make up for the skipped one.


Q: Can Metoclopramide Syrup cause changes in bowel movements?

Official documentation of adverse reactions notes that effects on the gastrointestinal system are common. Specifically, diarrhoea is classified as a commonly occurring side effect that has been observed in patients using this medication.


Q: What is the difference between Metoclopramide and another common anti-nausea drug, like ondansetron?

Metoclopramide is classified as both a prokinetic agent and an antiemetic. This means it is officially recognized for both promoting upper digestive movement and suppressing the central signals for sickness. This dual mechanism is the primary way the medication's action is defined.


Q: What is the maximum duration of use generally mentioned in official documentation?

The duration of use is regulated and varies based on the condition and region. Official documents indicate a maximum duration of 5 days for acute symptoms in some regions, while for chronic conditions, it generally should not exceed 12 weeks. These duration limits are specified in regulatory labeling due to the risk of serious neurological side effects.


Q: Does Metoclopramide Syrup affect blood pressure?

Official safety labeling includes reports of cardiovascular events such as hypotension (low blood pressure) and hypertension (high blood pressure) among its potential adverse effects. A history of pheochromocytoma is listed as a contraindication due to the risk of a severe hypertensive crisis.


Q: Does Metoclopramide Syrup contain sugar or is it safe for diabetics?

Some formulations of the oral solution, particularly those in certain regions, are specifically noted as being sugar-free and may use alternative sweeteners. Official labeling acknowledges use in patients with diabetic gastroparesis, but this condition requires specific consideration and potential dose adjustments.


Q: Can Metoclopramide Syrup affect my mood or cause anxiety?

Official safety labeling lists psychiatric side effects, including depression and confusion. Motor restlessness (akathisia) is also noted and can be accompanied by feelings of anxiety and agitation.


Q: Is Metoclopramide Syrup safe to use if I have an allergy to certain dyes or preservatives?

Some formulations of the syrup contain excipients (inactive ingredients) such as parahydroxybenzoates. These substances are noted in official product information as being capable of causing allergic reactions, which may sometimes be delayed.


Q: Is Metoclopramide Syrup prescribed for infant reflux?

Official eligibility documents confirm that use in infants under 1 year of age is explicitly contraindicated (not permitted). Use in older children is restricted and generally limited to specific, second-line indications with strict duration limits.


Q: Why is the use of Metoclapromide restricted in some countries?

Regulatory restrictions on this drug, such as strict limits on the duration of use and specific restrictions in children, are in place due to the known risk of neurological side effects. These serious effects include extrapyramidal disorders, which are movement-related issues.


Q: Is Metoclopramide Syrup an antibiotic?

No, Metoclopramide is not an antibiotic. It is officially classified as a prokinetic agent and an antiemetic. It belongs to the benzamide derivative chemical class, which influences the digestive system and central nervous system signals.


Q: Is there a generic version of Metoclopramide Syrup?

Yes, official drug availability records show that the active ingredient metoclopramide hydrochloride has been approved by the FDA as a generic product for the oral solution form.


Q: Does Metoclopramide Syrup interact with birth control pills?

Yes, due to its action on the digestive system, metoclopramide may modify the rate of absorption of other oral medications, including oral contraceptives. Because of this potential interaction, some regulatory labeling indicates that additional contraceptive measures may be needed when these medications are used together.


Q: Is Metoclopramide Syrup a controlled substance?

No, Metoclopramide has been classified by the US Drug Enforcement Administration (DEA) as having no controlled substance schedule. It is a prescription-only medication.


Q: Are there different strengths of Metoclopramide Syrup available?

Yes, official product information confirms that the Metoclopramide Syrup is available in different strengths. A common strength is 1 mg of metoclopramide hydrochloride per milliliter of solution.

Advertisements

How should Metoclopramide Syrup be stored and disposed of?

Official Storage and Disposal Requirements

Metoclopramide Oral Solution must be stored according to regulatory labeling to maintain stability. The medicine requires storage at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with a strict instruction to not freeze the solution. The container must be kept closed tightly and stored in the original outer carton for protection from light.

Once the bottle is opened, the oral solution has a limited shelf-life and must be discarded after 30 to 60 days, depending on the specific product label. The medicine must be kept out of the sight and reach of children.

Disposal of any unused or expired product must follow local regulatory requirements. The FDA recommends using a drug take-back program or, if unavailable, mixing the medicine with an undesirable substance (such as used coffee grounds) before placing it in a sealed bag for household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Metoclopramide Syrup found in:

A-Z Index: